In human brains, increased FKBP51 levels were associated with increased Braak staging, suggesting that increased FKBP51 may also contribute to AD progression, potentially due to the pathogenesis exhibited in the rodent models24. This evidence concerns the gene FKBP5 and Alzheimer disease.